Abstract
On the first of January 2019, the European Committee on Antimicrobial Susceptibility Testing, EUCAST, introduced the concept of “area of technical uncertainty” (ATU). The aim was to report on the incidence of ATU test results in a selection of common bacterial species and the subsequent impact on antimicrobial resistance categorization and workload. A retrospective analysis of clinical samples collected from February 2019 until November 2019 was performed. Susceptibility to amoxicillin-clavulanic acid and piperacillin-tazobactam in Enterobacterales (Escherichia spp., Klebsiella spp., Proteus spp.), piperacillin-tazobactam in Pseudomonas aeruginosa, and amoxicillin-clavulanic acid and cefuroxime in Haemophilus influenzae was studied. Disk diffusion antibiotic susceptibility testing was read and interpreted by ADAGIO 93400 automated system (Bio-Rad, France). In case of an inhibition zone in the ATU, strains were retested using gradient minimal inhibitory concentration method (Etest, BioMérieux, France). Overall, 14,164 isolate-antibiotic combinations were tested in 7922 isolates, resulting in 1204 (8.5%) disk zone diameters in the ATU region. Retesting of ATUs with Etest resulted in a category change from S to R for amoxicillin-clavulanic acid in 63/498 (12.7%) of Escherichia spp., 2/58 (3.4%) of Klebsiella spp., 2/37 (5.4%) of Proteus spp., and 6/125 (4.8%) of Haemophilus influenzae. For piperacillin-tazobactam, a category change from S to R was found in 33/92 (35.9%) of Pseudomonas aeruginosa. We conclude that ATU testing has a substantial impact on the correct interpretation of antimicrobial resistance, at the expense of turn-around time and with the cost of additional workload.
Similar content being viewed by others
Data availability
Not applicable
Code availability
Not applicable
References
Kahlmeter G (2017) EUCAST proposes to change the definition and usefulness of the susceptibility category “Intermediate.” Clin Microbiol Infect 23:894–895. https://doi.org/10.1016/j.cmi.2017.08.015
The European Committee on Antimicrobial Susceptibility Testing (2019) The implementation of the new definitions of S, I and R. https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/EUCAST_Presentations/2018/EUCAST_-_Intermediate_category_-_information_for_all.pdf. Accessed 10 Nov 2020
The European Committee on Antimicrobial Susceptibility Testing (2019) Breakpoint tables for interpretation of MICs and zone diameters Version 9.0, valid from 2019-01-01. https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_9.0_Breakpoint_Tables.pdf. Accessed 10 Nov 2020
Soares A, Pestel-Caron M, Leysour de Rohello F et al (2020) Area of technical uncertainty for susceptibility testing of amoxicillin/clavulanate against Escherichia coli: analysis of automated system, Etest and disk diffusion methods compared to the broth microdilution reference. Clin Microbiol Infect 26(12):1685.e1-1685.e6. https://doi.org/10.1016/j.cmi.2020.02.038
Ballestero-Téllez M, Jiménez-Morgades E, Arjona-Camacho P et al (2020) Inter-technique variability between antimicrobial susceptibility testing methods affects clinical classification of cefuroxime in strains close to breakpoint. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 26:648.e1-648.e3. https://doi.org/10.1016/j.cmi.2019.12.024
Acknowledgements
We thank all laboratory staff at the University Hospital Ghent, Belgium, for their contribution towards the survey.
Author information
Authors and Affiliations
Contributions
EVH was a major contributor to writing the manuscript. JB, LC, SVD, and BV checked and revised the manuscript. All the authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval
Not required
Consent to participate
Not applicable
Consent for publication
All the authors agree for publication of this manuscript.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Van Honacker, E., Vandendriessche, S., Coorevits, L. et al. Impact of the introduction of EUCAST’s concept of “area of technical uncertainty”. Eur J Clin Microbiol Infect Dis 41, 203–207 (2022). https://doi.org/10.1007/s10096-021-04364-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-021-04364-6